Published online before print August 3, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
in murine hematopoietic stem/progenitor cells
,
,
Departments of *Cellular and Molecular Medicine and
Medicine, School of Medicine, and
Institute of Molecular Medicine, University of California, San Diego
@ To whom correspondence should be addressed. E-mail: mricote{at}cnic.es.
Because of the retinoic acid receptor-
(RAR
) genes involvement in acute promyelocytic leukemia, the important role of RARs in hematopoiesis is now well established. However, relatively few studies of hematopoiesis have focused on the role of the retinoid X receptors (RXRs), the obligate heterodimeric partners of the RARs. We sought to establish whether conditional targeting of RXR
in early hematopoietic progenitors, ideally to the level of the hematopoietic stem cell (HSC), would compromise hematopoiesis. For hematopoietic targeting of RXR
, we characterized IFN-inducible MxCre mice for use in studying the role of RXR
in hematopoiesis. We established that MxCre executes recombination of loxP-flanked RXR
in hematopoietic progenitors immunophenotypically enriched for HSC, leading to widespread and sustained targeting of RXR
in hematopoietic cells. However, we found no evidence of hematologic compromise in mice lacking RXR
, suggesting that RXR
is dispensable for normal murine hematopoiesis. Nonetheless, RXR
null bone marrow cells cultured in methylcellulose form colonies more efficiently than bone marrow cells obtained from control mice. This result suggests that although RXR
is not required for murine hematopoiesis, there may be hematopoietic signaling pathways that respond selectively to RXR
or settings in which combined expression of RXR (
,
, and
) is limiting.
Key Words: myelopoiesis nuclear receptors retinoid X receptors retinoic acid receptors
This article has been cited by other articles:
![]() |
J. P. Chute, J. R. Ross, and D. P. McDonnell Minireview: Nuclear Receptors, Hematopoiesis, and Stem Cells Mol. Endocrinol., January 1, 2010; 24(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Safi, G. G. Muramoto, A. B. Salter, S. Meadows, H. Himburg, L. Russell, P. Daher, P. Doan, M. D. Leibowitz, N. J. Chao, et al. Pharmacological Manipulation of the RAR/RXR Signaling Pathway Maintains the Repopulating Capacity of Hematopoietic Stem Cells in Culture Mol. Endocrinol., February 1, 2009; 23(2): 188 - 201. [Abstract] [Full Text] [PDF] |
||||